HALLOWEEN SALE - 25% OFF

NEW Selling losers for tax season? Check the wash-sale window first

Our free Wash Sale Calculator shows the first day you can buy back — and flags buys that would cancel your tax loss.

Check a trade »

STLN

STLN | NASDAQ

$6.89 $0.55 | 8.68%

TREND SIGNAL: Signal available — unlock to view

Signal available — unlock to view

|2026-11-03

Add to favoritesFavorite

Company Overview:

Market Cap: $705.82M

Trailing PE: N/A

FWD PE: —

Payout Ratio (TTM): —

52-Week Range: $4.75 - $7.13

0.3 Year STLN Performance Metrics:

Total Return (with DRIP): 44.4% (240.67% CAGR)

Total Return (no DRIP): 44.4% (240.67% CAGR)

Share Price: 44.4% (240.67% CAGR)

Yield on Cost (with DRIP): —

Total Invested: $10,000

Total Value (with DRIP): $14,444

Total Return $ (with DRIP): $4,444

STLN Total Return

1M 3M 6M YTD 1Y 3Y 5Y 10Y

STLN Price Chart

1M 3M 6M YTD 1Y 3Y 5Y 10Y All

Build Custom Charts

STLN - Chart 1

STLN - Chart 2

STLN - Chart 3

Unlock All Reports & Research Dividend Stocks like a BOSS!

Get 3 Months Free with Annual Plan

PRO

$171 ($14.25/mo) $128.25/yr ($10.69/mo)

7-day free trial

Unlimited Portfolio Tracker
Portfolio - Lots/Sales/Dividends
Portfolio Auto-DRIP
Trend Signals Dashboard
Stock Fundamentals
Compare Stocks Side-by-Side
Revenue & EPS Estimates
DCF Valuation Modeling

Try it free for 7 days

Combined 44% Lifetime Discount

Most Popular

PREMIUM

$288 ($24/mo) $216/yr ($18/mo)

7-day free trial

Everything in Pro
YieldMax PNL Tracker
YieldMax NAV Erosion Alerts
YM ETFs Trend Signals
9/21 EMA Trend Signals
Stocks Dashboard

Try it free for 7 days

Combined 44% Lifetime Discount

ULTRA

$576 ($48/mo) $432/yr ($36/mo)

7-day free trial

Everything in Premium
15min & 1hr Intraday Signals
Group & weekly ETF estimates
YouTuber Mode
Trades summary + CSV export
Priority data & support

Try it free for 7 days

Combined 44% Lifetime Discount

STLN Financials: Earnings, Revenue, Cash Flow, Ebitda, Cash/Debt, Shares Float, etc:

STLN - Revenue

STLN Revenue CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%

STLN - Earnings Per Share (EPS)

STLN EPS CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%

STLN - Net Income

🔓 See the full chart25% off right now · 7-day free trial

STLN Net Income CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%

STLN - EBITDA

🔓 See the full chart25% off right now · 7-day free trial

STLN EBITDA CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%

STLN - Free Cash Flow

🔓 See the full chart25% off right now · 7-day free trial

STLN Free Cash Flow CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%

STLN - Free Cash Flow / Share

🔓 See the full chart25% off right now · 7-day free trial

STLN Free Cash Flow / Share CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%

STLN - Operating Income

🔓 See the full chart25% off right now · 7-day free trial

STLN Operating Income CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%

STLN - Gross Profit

🔓 See the full chart25% off right now · 7-day free trial

STLN Gross Profit CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%

STLN - Shares Outstanding

🔓 See the full chart25% off right now · 7-day free trial

STLN Shares Outstanding CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%

STLN - Share Buybacks

🔓 See the full chart25% off right now · 7-day free trial

STLN Share Buybacks CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%

STLN - Stock-Based Comp

🔓 See the full chart25% off right now · 7-day free trial

STLN Stock-Based Comp CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%

STLN - Expenses

🔓 See the full chart25% off right now · 7-day free trial

STLN Expenses CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%

STLN - Revenue vs Net Income

🔓 See the full chart25% off right now · 7-day free trial

STLN - EPS vs FCF / Share

🔓 See the full chart25% off right now · 7-day free trial

STLN - EPS vs PE Ratio

🔓 See the full chart25% off right now · 7-day free trial

STLN - FCF vs FCF / Share

🔓 See the full chart25% off right now · 7-day free trial

STLN - FCF vs Stock Based Comp

🔓 See the full chart25% off right now · 7-day free trial

STLN - Cash & Debt

🔓 See the full chart25% off right now · 7-day free trial

Revenue, EPS, Net Income & Ebitda - Estimates VS Actual:

STLN - REVENUE: Actual + Estimates

🔓 See the full chart25% off right now · 7-day free trial

STLN Actual Revenue CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%

STLN - EPS: Actual + Estimates

🔓 See the full chart25% off right now · 7-day free trial

STLN Actual EPS CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%

STLN - NET INCOME: Actual + Estimates

🔓 See the full chart25% off right now · 7-day free trial

STLN Actual Net Income CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%

STLN - EBITDA: Actual + Estimates

🔓 See the full chart25% off right now · 7-day free trial

STLN Actual EBITDA CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%

Ratios, Profit Margins & Return on Capital:

STLN - Net Profit Margin

🔓 See the full chart25% off right now · 7-day free trial

STLN Net Profit Margin CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%

STLN - Gross Profit Margin

🔓 See the full chart25% off right now · 7-day free trial

STLN Gross Profit Margin CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%

STLN - Price to Earnings

🔓 See the full chart25% off right now · 7-day free trial

STLN Price to Earnings CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%

STLN - Price To Sales Ratio

🔓 See the full chart25% off right now · 7-day free trial

STLN Price To Sales Ratio CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%

STLN - Return on Capital Employed

🔓 See the full chart25% off right now · 7-day free trial

STLN Return on Capital Employed CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%

STLN - Return on Invested Capital

🔓 See the full chart25% off right now · 7-day free trial

STLN Return on Invested Capital CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%

Projected Future Returns & Dividends for STLN

Based on past 0.3-year performance, here are STLN growth metrics:

Share price CAGR of +240.67%
Dividend CAGR of +0%

Using STLN CAGR metrics, we can estimate that your initial $10000 investment, over the next 10 years, should grow as follows:

	STLN (DRIP)	STLN - No DRIP
Current Price	$6.89	$6.89
Start Shares	1,451.38	1,451.38
Start Value	$10,000	$10,000

After 10 years:
Final Share Count	1,451.38	1,451.38
Dividends Payment	$0.00	$0.00
Annual Dividends	$0	$0
Yield on cost	0.00%	0.00%
Share Price	$6.89	$6.89
Total Dividends	$0	$0
Final Value	$10,000	$10,000

Estimated Future Value + Dividends - STLN

NOTE: Above numbers are our estimate based on STLN's Dividend and Price CAGR over past 0.3 years. These numbers should only be considered as "potential future returns"! DRIP assumes reinvesting dividends; No-DRIP assumes collecting dividends as cash.

We cannot guarantee that your actual returns will meet these estimates.

Get the best Dividend Stock Research Tools:

Get 3 Months Free with Annual Plan

PRO

$171 ($14.25/mo) $128.25/yr ($10.69/mo)

7-day free trial

Unlimited Portfolio Tracker
Portfolio - Lots/Sales/Dividends
Portfolio Auto-DRIP
Trend Signals Dashboard
Stock Fundamentals
Compare Stocks Side-by-Side
Revenue & EPS Estimates
DCF Valuation Modeling

Try it free for 7 days

Combined 44% Lifetime Discount

Most Popular

PREMIUM

$288 ($24/mo) $216/yr ($18/mo)

7-day free trial

Everything in Pro
YieldMax PNL Tracker
YieldMax NAV Erosion Alerts
YM ETFs Trend Signals
9/21 EMA Trend Signals
Stocks Dashboard

Try it free for 7 days

Combined 44% Lifetime Discount

ULTRA

$576 ($48/mo) $432/yr ($36/mo)

7-day free trial

Everything in Premium
15min & 1hr Intraday Signals
Group & weekly ETF estimates
YouTuber Mode
Trades summary + CSV export
Priority data & support

Try it free for 7 days

Combined 44% Lifetime Discount

Company Info

Starling Oncology Inc. (STLN) had its IPO on , and is traded on NASDAQ stock exchange.

Starling Oncology Inc. is a healthcare company focused on delivering specialized, value-based cancer care through a community-based oncology platform. The company provides physician-led oncology services that include cancer diagnosis and treatment, in-house infusion, specialty pharmacy support, clinical trials, radiation oncology, transfusion services, and coordinated patient support. Its integrated model is designed to manage care across multiple touchpoints, helping patients navigate treatment with access to medication management, case coordination, and ongoing clinical assistance. Starling Oncology serves adult and senior cancer patients through clinics and affiliated care sites across several U.S. states, making it a significant provider in community oncology. The company’s current business is centered on combining advanced cancer therapies with accessible local care delivery for patients and payors.

STLN website: https://starlingoncology.com

Get Full Access to All Reports with DRIPCalc PRO

Get 3 Months Free with Annual Plan

PRO

$171 ($14.25/mo) $128.25/yr ($10.69/mo)

7-day free trial

Unlimited Portfolio Tracker
Portfolio - Lots/Sales/Dividends
Portfolio Auto-DRIP
Trend Signals Dashboard
Stock Fundamentals
Compare Stocks Side-by-Side
Revenue & EPS Estimates
DCF Valuation Modeling

Try it free for 7 days

Combined 44% Lifetime Discount

Most Popular

PREMIUM

$288 ($24/mo) $216/yr ($18/mo)

7-day free trial

Everything in Pro
YieldMax PNL Tracker
YieldMax NAV Erosion Alerts
YM ETFs Trend Signals
9/21 EMA Trend Signals
Stocks Dashboard

Try it free for 7 days

Combined 44% Lifetime Discount

ULTRA

$576 ($48/mo) $432/yr ($36/mo)

7-day free trial

Everything in Premium
15min & 1hr Intraday Signals
Group & weekly ETF estimates
YouTuber Mode
Trades summary + CSV export
Priority data & support

Try it free for 7 days

Combined 44% Lifetime Discount

Loading signals…

DCF Model — STLN

Value from:

EPS (TTM)icompany profit per share over the last 12 months

EPS Growth %ihow fast profit per share grows each of the next 5 years — prefilled with what analysts expect

EPS growth after year 5 (forever)ithe slower pace once the fast 5 years are over — only drives years 6-10 of the price path below

Exit multiple (PE in 5 yrs)iwhat buyers pay per $1 of profit in 2031 — prefilled with today’s forward PE

Desired return %/yrithe yearly return you want from buying today — the S&P has done ~14%/yr, ask for more from a single stock

FCF growth %/yr (next 5 yrs)ihow fast free cash flow grows while the company is still expanding fast

Years of fast FCF growthihow many years the fast growth lasts before the business settles down

FCF growth after year 5 (forever)ithe slow, steady pace once the company is mature — usually 2-3%, near inflation. Must stay below your target return

Risk-free rate %iwhat a 10-yr US treasury pays with zero risk — the floor any risky stock must beat

Your target return %/yrithe yearly return you want for taking this risk — rule of thumb: risk-free rate + extra for risk

FCF base ($M, TTM)ilast 12 months of free cash flow, added up from reported quarters

Include dividends in returnidividends hand you part of the return in cash, so the share price needs to climb less

Pay up to today

—

vs current price $6.89

—

Cash flow & implied price by year

FCF is negative or missing for this company (common for banks) — the model discounts EPS instead.

EPS is negative or missing for this company — Simple mode uses free cash flow per share instead.

Free cash flow today

—

grows for the next years

Then mature

—

every future dollar counted back to today

Pile of today-dollars

—

÷ shares

Implied price path

Year	FCF	Implied price

Sensitivity — fair value: growth ↓ × target return →

× Free Portfolio Tracker

Own STLN? See what your shares are worth

Add your STLN shares to a free account and see what they're worth at today's price, what you paid, and your gain or loss. Room for 4 more stocks.

✓Your STLN shares valued at today's price
✓What you paid, and your gain or loss
✓Up to 5 stocks tracked in one place

Add STLN free →

Free plan · up to 5 holdings